HOME >> BIOLOGY >> NEWS
Open source and open medicine take centre stage at UN research symposium

Can an Intellectual Property regime designed to protect private interests be reformed to "lock everyone in"? What results when government authorities promote free, open source software in their jurisdictions? Who (if anyone) should own or control access to the human genome sequence? What parallels can be drawn with the fundamental principles of 'openness' for science and society as a whole?

These and a host of other issues will be explored at a research symposium titled Challenging Intellectual Property: Access to Knowledge Issues in Open Source and Medicine that takes place on Thursday 13 April 2006 at the UN Headquarters in New York. The event is organized by the United Nations University at the United Nations, New York, and United Nations University - Maastricht Economic and social Research and training centre on Innovation and Technology (UNU-MERIT) in the Netherlands.

The Symposium will analyse the role of Free/Open Source Software and other collaborative models of knowledge production in economic development. It will also assess the effectiveness of several alternative global financing mechanisms that have been proposed to boost health research and development, and broaden access to affordable drugs for the world's poorest populations.

The speakers include:

  • Rishab Aiyer Ghosh, Senior Researcher, UNU-MERIT;
  • Louis-Dominique Oudraogo, retiring Inspector, the UN Joint Inspection Unit;
  • Tim Hubbard, Head of Human Genome Analysis, The Wellcome Trust Sanger Institute, UK;
  • Renato da Silveira Martini, Director-General, ITI (National Institute of IT, Brazil).

At a time of growing economic and social disparities within and across countries and regions - coupled with diminishing returns on R&D investments despite stronger intellectual property protection a range of governments and non-governmental groups in technologically advanced and developing countries alike have called for
'"/>

Contact: Louise Bergstrom
unuona@ony.unu.edu
212-963-6387
United Nations University
13-Apr-2006


Page: 1 2 3

Related biology news :

1. Pets could be source of multiresistant bacteria infections in humans, MU researchers investigate
2. Bright future for nano-sized light source
3. Pointing a finger at the source of fecal bacteria
4. Alien plants attack using resource conservation as weapon, researchers say
5. Supermap of avian flu yields new info on source/spread
6. ESA open-source software supports Germanys TerraSAR-X
7. New agreement helps protect thousands of rice varieties -- the planets most important food source
8. Invitrogen features new scientific online resources at ASCB Meeting
9. Mixed prairie grasses are better biofuel source, U of M study says
10. Ocean sampling yields environmental sources of coral symbionts
11. Forum to explore thorium as abundant source of clean energy

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Open source and open medicine take centre stage research symposium

(Date:6/29/2015)... 2015 Research and Markets( ... "Latin America Biomedical Sensors Market - Growth, Trends & ... The Latin America Biomedical Sensors market is estimated at ... over the period 2014-2020 The near future ... genetic formulation of each individual. These sensors can be ...
(Date:6/25/2015)... , June 25, 2015  TAKE Solutions Ltd., ... patent by the United States Patent and Trademark Office ... This process leverages TAKE Solutions, Clinical Accelerators to reduce ... 50% (when compared to standardization without the accelerators), thus ... At the heart of the ...
(Date:6/24/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/hhwlfj/huawei_ascend ... "Huawei Ascend Mate 7 Fingerprint Sensor - Reverse ... Huawei,s technological choice for the fingerprint sensor ... and Samsung,s one. The Ascend Mate 7 presents ... a main actor in capacitive sensing human interface ...
Breaking Biology News(10 mins):Latin America Biomedical Sensors Market Report 2015-2020 2TAKE Solutions Awarded Patent By USPTO 2Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2
(Date:7/1/2015)... YORK , July 1, 2015  UCB, ... G ), a global leader in designing, transforming, ... Aecus Innovation Award in recognition of their close ... efficiencies in UCB,s global business services (GBS) finance ... service providers and clients that work together effectively ...
(Date:6/30/2015)... WASHINGTON , June 30, 2015  NASA astronaut ... launch next month on his first mission to the ... interviews from 8 to 9 a.m. EDT Tuesday, July 7. ... Center in Star City, Russia . The ... on NASA Television highlighting his mission training. To ...
(Date:6/30/2015)... ... June 30, 2015 , ... Noblis, ... government, announced in a paper published this week in the scientific journal Viruses ... the diagnostic techniques currently used to detect the Ebola virus. Noblis worked with ...
(Date:6/30/2015)... June 30, 2015 /PRNewswire/ - RepliCel Life Sciences ... regenerative medicine company focused on the development of ... in its Phase 1/2 clinical trial of RCT-01, ... Achilles tendinosis, has been enrolled and their tissue ... injections. RCT-01 is comprised of non-bulbar dermal sheath ...
Breaking Biology Technology:UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 2UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 3UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 4UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 5NASA Astronaut Preps for First Space Station Mission, Available for Media Interviews 2Noblis and Government Scientists Identify New Genomic Signatures of Ebola Using Whole Genomic Sequencing and Innovative BioVelocity Analytics Tool 2Noblis and Government Scientists Identify New Genomic Signatures of Ebola Using Whole Genomic Sequencing and Innovative BioVelocity Analytics Tool 3Noblis and Government Scientists Identify New Genomic Signatures of Ebola Using Whole Genomic Sequencing and Innovative BioVelocity Analytics Tool 4RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 2RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 4
Cached News: